Early Detection of Prostate Cancer — Time to Fish or Cut Bait

2nd Dec, 2025

Hematology/Oncology

The New England Journal of Medicine

Approaches to early detection of cancer often seem contentious, but the big-picture view is actually one of remarkable consensus. All major guideline groups recommend the Papanicolaou smear, mammography, colonoscopy, and — in older adults with a substantial history of smoking — lung imaging; none recommend CA-125 for early detection of…

Published By: The New England Journal of Medicine

Hematology/Oncology

11th Mar, 2026

The New England Journal of Medicine

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer

Hematology/Oncology

11th Mar, 2026

The New England Journal of Medicine

Heads or the Tail?

Hematology/Oncology

11th Mar, 2026

The New England Journal of Medicine

Biting the Tail of CAR-T for Relapsed Multiple Myeloma

Hematology/Oncology

11th Mar, 2026

The New England Journal of Medicine

Gene Therapy for Nephropathic Cystinosis

Hematology/Oncology

11th Mar, 2026

The New England Journal of Medicine

Hematopoietic Stem-Cell Gene Therapy for Cystinosis

Hematology/Oncology

11th Mar, 2026

The New England Journal of Medicine

Hitting the Mark — Individualizing Therapy for HER2-Positive Early-Stage Breast Cancer

Hematology/Oncology

11th Mar, 2026

The New England Journal of Medicine

Early Detection of Prostate Cancer — Time to Fish or Cut Bait

Related Articles

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer

Heads or the Tail?

Biting the Tail of CAR-T for Relapsed Multiple Myeloma

Gene Therapy for Nephropathic Cystinosis

Hematopoietic Stem-Cell Gene Therapy for Cystinosis

Hitting the Mark — Individualizing Therapy for HER2-Positive Early-Stage Breast Cancer

Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors

Early Detection of Prostate Cancer — Time to Fish or Cut Bait

Related Articles

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer

Heads or the Tail?

Biting the Tail of CAR-T for Relapsed Multiple Myeloma

Gene Therapy for Nephropathic Cystinosis

Hematopoietic Stem-Cell Gene Therapy for Cystinosis

Hitting the Mark — Individualizing Therapy for HER2-Positive Early-Stage Breast Cancer

Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors